Reuters logo
BRIEF-Pfizer receives approval in the european union for nimenrix in infants six weeks of age and older
December 19, 2016 / 12:22 PM / 9 months ago

BRIEF-Pfizer receives approval in the european union for nimenrix in infants six weeks of age and older

Dec 19 (Reuters) - Pfizer Inc -

* Pfizer receives approval in the european union for nimenrix(TM) (meningococcal group A, C, W-135, and Y conjugate vaccine) in infants six weeks of age and older Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below